D.E. Shaw & Co’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,200
Closed -$322K 5393
2022
Q3
$322K Buy
+10,200
New +$330K ﹤0.01% 4264
2021
Q2
Sell
-11,347
Closed -$298K 5191
2021
Q1
$298K Buy
+11,347
New +$270K ﹤0.01% 3710
2020
Q4
Sell
-34,034
Closed -$578K 4283
2020
Q3
$578K Sell
34,034
-136,560
-80% -$2.65M ﹤0.01% 3154
2020
Q2
$3.97M Sell
170,594
-469,401
-73% -$6.8M 0.01% 1831
2020
Q1
$5.38M Buy
639,995
+10,588
+2% +$89.1K 0.01% 1415
2019
Q4
$6.15M Sell
629,407
-10,399
-2% -$97.6K 0.01% 1569
2019
Q3
$6.07M Buy
639,806
+19,928
+3% +$210K 0.01% 1496
2019
Q2
$7.36M Buy
619,878
+235,171
+61% +$2.83M 0.01% 1310
2019
Q1
$6.78M Buy
384,707
+467
+0.1% +$7.77K 0.01% 1351
2018
Q4
$6.67M Buy
384,240
+40,236
+12% +$686K 0.01% 1346
2018
Q3
$5.13M Buy
344,004
+63,837
+23% +$990K 0.01% 1572
2018
Q2
$4.46M Buy
280,167
+80,960
+41% +$1.21M 0.01% 1629
2018
Q1
$2.83M Buy
199,207
+25,574
+15% +$378K ﹤0.01% 1796
2017
Q4
$2.43M Buy
173,633
+123,155
+244% +$1.8M ﹤0.01% 2000
2017
Q3
$722K Buy
50,478
+37,813
+299% +$540K ﹤0.01% 2697
2017
Q2
$199K Buy
12,665
+277
+2% +$3.99K ﹤0.01% 3194
2017
Q1
$171K Sell
12,388
-80,315
-87% -$1.12M ﹤0.01% 3143
2016
Q4
$1.64M Sell
92,703
-9,081
-9% -$160K ﹤0.01% 2146
2016
Q3
$1.96M Buy
101,784
+14,220
+16% +$278K ﹤0.01% 1936
2016
Q2
$1.71M Buy
87,564
+57,047
+187% +$1.12M ﹤0.01% 2040
2016
Q1
$629K Sell
30,517
-19,376
-39% -$382K ﹤0.01% 2660
2015
Q4
$1.02M Sell
49,893
-27,500
-36% -$527K ﹤0.01% 2619
2015
Q3
$1.32M Sell
77,393
-79,602
-51% -$1.45M ﹤0.01% 2408
2015
Q2
$2.93M Buy
156,995
+27,340
+21% +$507K 0.01% 1888
2015
Q1
$2.47M Buy
129,655
+56,265
+77% +$1.04M ﹤0.01% 1852
2014
Q4
$1.21M Buy
73,390
+38,832
+112% +$666K ﹤0.01% 2679
2014
Q3
$611K Sell
34,558
-6,497
-16% -$128K ﹤0.01% 3191
2014
Q2
$847K Sell
41,055
-52,354
-56% -$1.08M ﹤0.01% 3086
2014
Q1
$2.04M Buy
+93,409
New +$2.14M ﹤0.01% 2372

Other funds holding VIVO